Navigation Links
Dr. Larry Corey Named New Member of the Institutes of Medicine

SEATTLE, Oct. 13 /PRNewswire/ -- Larry Corey, M.D., senior vice president and co-director of the Vaccine and Infectious Disease Institute at Fred Hutchinson Cancer Research Center, today was named as one of 65 new members of the prestigious Institutes of Medicine (IOM).

Election to the IOM is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service. Members are elected through a highly selective process that recognizes people who have made major contributions to the advancement of the medical sciences, health care, and public health.

"I am honored by the recognition," Corey said. With a tip of the hat to those who work in his labs, Corey added, "I thank all of the smart fellows, post docs, technicians and collaborators who have made me look so good over the years. I hope I continue to stay out of their way and allow them to pursue their ideas, with just the right touch of guidance from me."

With their election to the IOM, members make a commitment to volunteer a significant amount of time to IOM committees, which engage in a broad range of studies on health policy issues.

Corey is principal investigator of the HIV Vaccine Trials Network, which is based at the Hutchinson Center. He is also head of the University of Washington's Virology Division and is a professor of medicine and laboratory medicine at the UW School of Medicine.

Research in Corey's labs includes studies dealing with the pathogenesis, prevention and treatment of HIV and herpes virus infections. These investigations include the development of experimental vaccines for both genital herpes and HIV. The labs have also pioneered novel tests for diagnosing and monitoring therapies for viral infections.

Contact: Kristen Woodward, 206-667-5095 or

SOURCE Fred Hutchinson Cancer Research Center
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. A Statement From Larry Corey, MD, of the HIV Vaccine Trials Network Regarding the New HIV Infection Statistics Released Today by the Centers for Disease Control
2. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
3. Todd R. Nelson Named Chief Executive Officer of eBioscience, Inc.
4. Miaxis Biometrics Named as Red Herring 100 Asia Award Winner for 2007
5. Dr. Keith Wilson Named President and Chief Scientific Officer of Takeda San Diego
6. Hyaluron Contract Manufacturing Named a 2007 Economic Impact Award Finalist
7. Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association
8. Baxter Named to Dow Jones Sustainability Index for Ninth Consecutive Year
9. PharmAthene Named as Contractor in $13.9 Million Award Notice Published by the Department of Health and Human Services
10. Ikaria Founding Scientist Named 2007 MacArthur Fellow
11. BoVir(R) Named Best New Veterinary Diagnostics Product in International Animal Pharm Awards
Post Your Comments:
(Date:11/27/2015)... PUNE, India , November 27, 2015 ... --> Growing popularity of companion ... emerging in cancer biomarkers market with pharmaceutical ... develop in-demand companion diagnostic tests. ... --> Complete report on global ...
(Date:11/26/2015)... , November 26, 2015 ... device company specializing in imaging technologies, announced today that it ... as part of the Horizon 2020 European Union Framework Programme ... a large-scale clinical trial in breast cancer. , ... , --> --> The ...
(Date:11/25/2015)... Nov. 25, 2015  PharmAthene, Inc. (NYSE MKT: PIP) ... a stockholder rights plan (Rights Plan) in an effort ... carryforwards (NOLs) under Section 382 of the Internal Revenue ... PharmAthene,s use of its NOLs could be substantially ... defined in Section 382 of the Code. In general, ...
(Date:11/25/2015)... November 25, 2015 Studies reveal ... human plaque and pave the way for more effective treatment ... cats     --> ... diagnosed health problems in cats, yet relatively little was understood ... collaborative studies have been conducted by researchers from the WALTHAM ...
Breaking Biology Technology:
(Date:11/17/2015)... Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and ... of broadly enabling, pressure cycling technology ("PCT")-based sample preparation ... it has received gross proceeds of $745,000 from an ... "Offering"), increasing the total amount raised to date in ... are expected in the near future. ...
(Date:11/12/2015)... 12, 2015  A golden retriever that stayed healthy ... (DMD) has provided a new lead for treating this ... Broad Institute of MIT and Harvard and the University ... Cell, pinpoints a protective gene ... disease,s effects. The Boston Children,s lab of Lou ...
(Date:11/12/2015)... , Nov. 11, 2015   Growing need ... analytical tools has been paving the way for ... determination of discrete analytes in clinical, agricultural, environmental, ... being predominantly used in medical applications, however, their ... sectors due to continuous emphasis on improving product ...
Breaking Biology News(10 mins):